Volume 63, Issue 6, Pages (June 2003)

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Lilia Cervantes, Monica Grafals, Rudolph A. Rodriguez

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

End-stage renal disease in developing countries

Volume 83, Issue 3, Pages (March 2013)

Robert W. Schrier, Kimberly K. McFann, Ann M. Johnson

Kidney transplantation in a low-resource setting: Nigeria experience

Reassessment of the care of the patient with chronic kidney disease

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Section 5: Dialysis Interventions for Treatment of AKI

Burden of chronic kidney disease: North Africa

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Francesco Paolo Schena Kidney International

Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating Wim Van Biesen, Achim Jörres Kidney International

Volume 63, Issue 3, Pages (March 2003)

Volume 70, Pages S21-S25 (December 2006)

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 72, Issue 9, Pages (November 2007)

Comorbidity and confounding in end-stage renal disease

Volume 70, Issue 11, Pages (December 2006)

Late referral and modality choice in end-stage renal disease

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Fructose intake as a risk factor for kidney stone disease

Volume 76, Issue 6, Pages (September 2009)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Alternate-day dialysis may be needed for hemodialysis patients

Nephrology Crossword: Peritoneal Dialysis

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 61, Issue 1, Pages (January 2002)

Volume 81, Issue 9, Pages (May 2012)

Prehypertension: is it relevant for nephrologists?

Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes Sr. Anne B. Bakewell, Rob M. Higgins, Mair.

Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell Kara K. Wools-Kaloustian, Samir K. Gupta Kidney.

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Peritoneal dialysis in Mexico

Clinical benefits of slowing the progression of renal failure

Low triiodothyronine and survival in end-stage renal disease

The Iranian model of living renal transplantation

Volume 55, Pages S3-S16 (June 1999)

Elevated plasma F2-isoprostanes in patients on long-term hemodialysis

Volume 66, Issue 3, Pages (September 2004)

Charles A. Herzog Kidney International

Is complement a target for therapy in renal disease?

Volume 86, Issue 2, Pages (August 2014)

Volume 75, Issue 7, Pages (April 2009)

Changes to the End-Stage Renal Disease Quality Incentive Program

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 88, Issue 5, Pages (November 2015)

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Volume 67, Issue 4, Pages (April 2005)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Letter from W. Lornoy; I. Becaus; J.M. Billiouw and L. Sierens

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 63, Issue 6, Pages 2295-2301 (June 2003) The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis Lynda Anne Szczech, Robert Kalayjian, Rudolph Rodriguez, Samir Gupta, Joseph Coladonato, Jonathan Winston Kidney International Volume 63, Issue 6, Pages 2295-2301 (June 2003) DOI: 10.1046/j.1523-1755.2003.00031.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Dosing strategies. (A) Frequency of dosing strategies for lamivudine. Dose for end-stage renal disease (ESRD) patient suggested at 50mg initially, then 25mg each thereafter. **Patient received 150mg three times a week (following each dialysis treatment. (B) Frequency of dosing strategies for zidovudine. Dose for ESRD suggested at 100mg every 6 to 8 hours. †Patient received 100mg three times a week (following each dialysis treatment). Kidney International 2003 63, 2295-2301DOI: (10.1046/j.1523-1755.2003.00031.x) Copyright © 2003 International Society of Nephrology Terms and Conditions